More articles from Lung cancer

Crosstalk between Metformin and angiogenesis in lung cancer model
Jiun-Long Wang, Chuan-Mu Chen

European Respiratory Journal Sep 2023, 62 (suppl 67) PA2205; DOI: 10.1183/13993003.congress-2023.PA2205
COPD patients with NSCLC respond better to immune checkpoints inhibitors
Augustin Boudoussier, Iban Larrouture, Pauline Henrot, Remi Veillon, Claire Bardel, Camille Chautemps, Pierre Schilfarth, Maeva Zysman

European Respiratory Journal Sep 2023, 62 (suppl 67) PA2216; DOI: 10.1183/13993003.congress-2023.PA2216
Cancer-related mutations in non-tumoral respiratory epithelium: long-term prognosis.
Roberto Chalela Rengifo, Emanuel Carmona, Albert Sánchez-Font, Víctor Curull, Pedro Rocha, Diana Badenes, Raquel Longarón, Joaquín Gea, Ignacio Sánchez-Guerri, Beatriz Bellosillo

European Respiratory Journal Sep 2023, 62 (suppl 67) PA2201; DOI: 10.1183/13993003.congress-2023.PA2201
Understanding BRAF mutation in non-small cell lung cancer patients
Mariaenrica Tine, Giulia Squarzoni, Davide Ortolan, Federica Pezzuto, Fiorella Calabrese, Giulia Squarzoni

European Respiratory Journal Sep 2023, 62 (suppl 67) PA2210; DOI: 10.1183/13993003.congress-2023.PA2210
Study of the efficacy of intravenous BCG in a metastatic lung adenocarcinoma mouse model.
Claudia Guerrero, Eduardo Moreo, Santiago Uranga, Ana Belen Gomez, Carlos Martín, Nacho Aguiló

European Respiratory Journal Sep 2023, 62 (suppl 67) PA1713; DOI: 10.1183/13993003.congress-2023.PA1713
Exploiting the kynurenine pathway to combat platinum-resistant non-small cell lung cancer (NSCLC)
Medhi Wangpaichitr, Chunjing Wu, George Theodore, Sydney Spector, Dan Nguyen, Lynn Feun, Niramol Savaraj

European Respiratory Journal Sep 2023, 62 (suppl 67) PA1712; DOI: 10.1183/13993003.congress-2023.PA1712
Evaluation of adverse events of tremelimumab, a recently FDA-approved anti-CTLA-4 antibody for non-small cell lung cancer
Jing Huang, Yibei Zhao, Long Meng

European Respiratory Journal Sep 2023, 62 (suppl 67) PA1709; DOI: 10.1183/13993003.congress-2023.PA1709
CD8+ T cell trajectory subtypes determine clinical outcome and therapy response in LUAD
Benteng Deng, Jianlong Jia, Lingru Kang, Lilith Trassl, Daniela Dietel, Dmytro Sirokha, Andrea Schamberger, Asma Snkar, Georgios Stathopoulos, Isis Fernandez

European Respiratory Journal Sep 2023, 62 (suppl 67) PA1702; DOI: 10.1183/13993003.congress-2023.PA1702
Smoking status at time of diagnosis affects the efficacy of anti-PD-1/L1 therapy in patients with advanced non-small cell lung cancer
Kim Kyu Yean, Kim Jin Woo, Yeo Chang Dong

European Respiratory Journal Sep 2023, 62 (suppl 67) PA1707; DOI: 10.1183/13993003.congress-2023.PA1707
The long-term outcome of epidermal growth factor receptor mutation in stage IV lung adenocarcinoma patients.
Chung-Jen Huang, Justin Chen, An-Chen Feng, Cynthia Lin

European Respiratory Journal Sep 2023, 62 (suppl 67) PA1704; DOI: 10.1183/13993003.congress-2023.PA1704

Main menu

User menu

Search

More articles from Lung cancer

Pages

Contact us